Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Alkem Increases COPD Awareness Efforts through “Healthy Lungs” on World COPD Day Business
  • SCMS Bengaluru BBA Admissions via SET 2026: Apply for SET by 15 April and SCMS Bengaluru Registration by 21 May Education
  • Anticipated award winning Bollywood film “Sirf Money” to hit the theatres Nationwide on 4th August, 2023 Business
  • Superstar Kichcha Sudeepa Acquires Bengaluru Racing Team the Indian Racing Festival — Launches ‘Kichcha’s Kings Bengaluru’ Press Release
  • Hollywood Director Bronwen Hughes of ‘Breaking Bad’ Fame Lands in Mumbai for Untitled Indo-Global Rom-Com Entertainment
  • 8000+ Enthusiasts Learn About the Future of Options Trading at Indian Options Conclave 4.0 Business
  • Boney Kapoor Launches Actress Krishna Gautam’s Heartfelt Song “Baddua” Entertainment
  • Falguni Pathak’s Garba RAMZAT to be back again for its 6th year of astounding success in Borivali Entertainment

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Healing Hospital Chandigarh Achieves Groundbreaking Success in Sleep Apnea Surgery for High BMI Patient Health
  • World Heart Day 2025: Rising Heart Disease in the Young – Why Waiting Is Dangerous Health
  • Healing Hospital Chandigarh Named Best Private Hospital by Hon’ble Governor, Launches TB Support Initiative Health
  • The Hidden Dangers of Modern Lifestyle Habits: A Growing Cancer Concern Health
  • Transforming Cancer Care: EarlySure Diagnostics Brings Precision Oncology to India Health
  • Autism Treats with Immunotherapy Health

Recent Posts

  • Tips Music Ltd. Releases ‘Noor,’ A Romantic Track by Arslan Nizami and Duha Shah
  • Asha Bhosle No More: India’s Legendary Playback Singer Leaves Behind 11,000 Songs
  • Prateek Singh Joins Pocketful as CEO to Lead Next Phase of Growth
  • Sterling Biotech Resolution Achieves INR 9,800 Crore Recovery, Delivering a Clear Win–Win Outcome
  • The BL and GL Publishing House Indian Fandom Has Been Waiting For Is Here

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Choosing the Best Trading Platform in India for 2024 Business
  • Avani Institute of Design organizes innovative first-semester foundation studio exhibition ‘Museum in the Making’ Business
  • Vishwa Hindu Mahasangh Press Release
  • From Law to Leadership- The Journey of Aashruti Brahmbhatt Lifestyle
  • The Quintessential Indian Man: Festive Grooming Essentials for Men, With Denver Business
  • A 12th dropout, supporting Tribal Women through a unique Jamun-based Social Enterprise Model Business
  • Dev IT Strengthens Business Focus and Unlock the Value Through Transfer of ByteSIGNER and Talligence Business
  • They Had Islands. He Had a Street Light. Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme